Dabigatran: patient management in specific clinical settings

Dabigatran, a direct thrombin inhibitor, is licensed for the prevention of venous thromboembolism after knee and hip replacement, the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and for the treatment of acute venous thromboembolism. As dabigatran has...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kyrle, Paul Alexander, Binder, Konrad, Eichinger, Sabine, Függer, Reinhold, Gollackner, Bernd, Hiesmayr, J. Michael, Huber, Kurt, Lang, Wielfried, Perger, Peter, Quehenberger, Peter, Roithinger, Franz X., Schmaldienst, Sabine, Weltermann, Ansgar, Domanovits, Hans
Format: Artigo
Idioma:Inglês
Publicat: Springer Vienna 2014
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4165862/
https://ncbi.nlm.nih.gov/pubmed/25138549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00508-014-0581-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars